This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on May 28, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
NOI - LC MS Analysis Processed Mouse Serum Samples
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, has issued a combined synopsis/solicitation under solicitation number 75N98026Q00465 for the LC-MS analysis of 280 processed mouse serum samples. This solicitation is being conducted as a non-competitive, firm fixed price purchase order pursuant to applicable federal acquisition regulations allowing streamlined procurement for commercial items without full and open competition. The acquisition leverages the proprietary Seer Proteograph Platform and Proteograph Analysis Suite (PAS), which are exclusively provided by Seer, Inc., making them the sole capable vendor to fulfill this requirement. NIH intends to award the contract directly to Seer, Inc., located in Redwood City, CA. The contract supports the analysis using liquid chromatography–mass spectrometry (LC-MS) to advance the study of mouse serum samples through Seer's unique proteomic workflow and software suite. The notice serves as the only solicitation for this procurement, with proposals due by June 8, 2026. The procurement falls under NAICS code 541380 and is managed within the NIH’s Office of Acquisitions, based in Bethesda, Maryland. Contact points for both NIH and Seer, Inc. have been provided to facilitate communication regarding this acquisition.
General Info
Agency
NAICS
Place of Performance
MDSet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
the format in FAR Subpart 12.6, as supplemented with additional information included in this
notice. This announcement constitutes the only solicitation; proposals are being requested, and a
separate written solicitation will not be issued.
(ii) The solicitation number is 75N98026Q00465. This solicitation is issued as a Notice of Intent
(NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase
order without providing for full and open competition (including brand-name, if applicable).
This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for
Commercial Products or Commercial Services, and is not expected to exceed the simplified
acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii).
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to
negotiate and award a firm fixed price Purchase Order on a non-competitive basis to:
Seer, Inc.
3800 Bridge Pkwy, Suite 102
Redwood City, CA 94065
Contact: Pierre Mbarushimana
Phone: 650-453-0901
Email: STAC-US@seer.bio
for LC-MS (liquid chromatography¿mass spectrometry) analysis of 280 processed mouse serum
samples using the proprietary Seer Proteograph Platform and Proteograph Analysis Suite (PAS).
Seer, Inc. is the sole provider of the Proteograph workflow, Proteograph Sample Kits, and PAS
software, and is therefore the only vendor capable of fulfilling this requirement as specified.
